Desenlaces de la hospitalización y síndrome post - agudo por COVID - 19

Introduction. 10-20 % of hospitalized patients for COVID - 19 have clinical manifestations lasting more than three weeks, particularly musculoskeletal symptoms (including arthralgia and myalgia), besides fatigue, insomnia, anxiety, and cognitive dysfunction, among others. Objective. We aimed to determine the frequency of post - acute COVID - 19 syndrome in those who had been hospitalized. Material and Methods. A cohort of COVID - 19 patients discharged from the hospital between April 2020 and March 2022. Data were obtained via telephone survey. Results. 82.8 % out of 128 patients were still alive 12 months after their hospital discharge; deaths were associated with voluntary discharges or refusal of intubation; 61.3 % reported good health. Clinical manifestations lasting more than three weeks occurred in 38.7 % (95 % CI: 29.9 % - 47.5 %). The most common ones were fatigue (50.9 %), dyspnea (46.2 %), arthralgia/myalgia (17 %), depression (10.4 %), and hair loss (12.3 %); 26.4 % continued with symptoms or signs 3 to 4 weeks post - discharge, 52.8 % had no medical follow - up, and 45.2 % sought private medical care; 82.1 % was vaccinated after discharge. Conclusions. Clinical manifestations of moderate to severe COVID - 19 remains high after hospital discharge in Mexican patients in this series.

Authors

Institutions

Publication Details

Journal
Latin American Journal of Clinical Sciences and Medical Technology
Published
2024-11-29
DOI
https://doi.org/10.34141/ljcs8207260
Primary Topic
Long-Term Effects of COVID-19
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Desenlaces de la hospitalización y síndrome post - agudo por COVID - 19

Celso Ramos, D. X. Xibille Friedmann, Eduardo Ortiz‐Panozo, A. Solano
Latin American Journal of Clinical Sciences and Medical Technology
Long-Term Effects of COVID-19
article

Desenlaces de la hospitalización y síndrome post - agudo por COVID - 19

Celso Ramos, D. X. Xibille Friedmann, Eduardo Ortiz‐Panozo, A. Solano
article en

Abstract

Introduction. 10-20 % of hospitalized patients for COVID - 19 have clinical manifestations lasting more than three weeks, particularly musculoskeletal symptoms (including arthralgia and myalgia), besides fatigue, insomnia, anxiety, and cognitive dysfunction, among others. Objective. We aimed to determine the frequency of post - acute COVID - 19 syndrome in those who had been hospitalized. Material and Methods. A cohort of COVID - 19 patients discharged from the hospital between April 2020 and March 2022. Data were obtained via telephone survey. Results. 82.8 % out of 128 patients were still alive 12 months after their hospital discharge; deaths were associated with voluntary discharges or refusal of intubation; 61.3 % reported good health. Clinical manifestations lasting more than three weeks occurred in 38.7 % (95 % CI: 29.9 % - 47.5 %). The most common ones were fatigue (50.9 %), dyspnea (46.2 %), arthralgia/myalgia (17 %), depression (10.4 %), and hair loss (12.3 %); 26.4 % continued with symptoms or signs 3 to 4 weeks post - discharge, 52.8 % had no medical follow - up, and 45.2 % sought private medical care; 82.1 % was vaccinated after discharge. Conclusions. Clinical manifestations of moderate to severe COVID - 19 remains high after hospital discharge in Mexican patients in this series.

Latin American Journal of Clinical Sciences and Medical TechnologyVol. 6(1)
Instituto Nacional de Salud Pública (MX)
Good health and well-being
Openalex Percentile: Top 64%
Long-Term Effects of COVID-19
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.